Related Experiment Video
Updated: Jul 5, 2026
06:48
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
Published on: May 31, 2020
Toward improved grading of malignancy in oligodendrogliomas using metabolomics
1Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Avenue Moliere, Strasbourg, France.
Magnetic Resonance in Medicine
|April 23, 2008
Summary
Metabolomic analysis of oligodendrogliomas using HRMAS NMR revealed distinct metabolic profiles differentiating tumor grades. This approach identified tumoral hypoxia as a key marker, offering a more accurate patient prognosis than traditional histopathology.
Area of Science:
- Neuro-oncology
- Metabolomics
- Biomarker Discovery
Background:
- Histopathological grading of oligodendrogliomas remains controversial.
- Reliable biomarkers are essential for improved patient therapeutic management.
Purpose of the Study:
- To investigate the metabolome of oligodendrogliomas to improve malignancy grading.
- To identify metabolic biomarkers differentiating low-grade (LGO) and high-grade (HGO) oligodendrogliomas.
- To correlate metabolic profiles with clinical patient evolution.
Main Methods:
- High-resolution magic angle spinning nuclear magnetic resonance spectroscopy (HRMAS NMR) on 34 human brain biopsies.
- Multivariate statistical analysis for classification and biomarker identification.
- Comparison of metabolic classification with histopathological grading and clinical outcomes.
Main Results:
- A classification model clearly distinguished between LGOs and HGOs based on their metabolomic profiles.
- Tumoral hypoxia was identified as a significant metabolic feature in HGOs.
- A gradient of tumoral hypoxia was observed: LGOs < intermediate oligodendrogliomas < HGOs < glioblastomas (GBMs).
- Metabolic classification showed a stronger correlation with patient clinical evolution than histopathology.
Conclusions:
- Metabolomics, particularly HRMAS NMR, provides valuable insights into oligodendroglioma malignancy grading.
- Tumoral hypoxia is a key metabolic indicator of tumor grade and progression.
- Metabolic profiling offers a potentially more accurate prognostic tool than histopathology for oligodendrogliomas.
